Showing results (1-10 of 6,994) with videos related to

Sort By:
Pageof 700
Lung Cancer (Amsterdam, Netherlands)|December 7, 2014
Clinicopathological analysis of pleomorphic carcinoma of the lung: diffuse ZEB1 expression predicts poor survivalSo Miyahara, Makoto Hamasaki, Daisuke Hamatake, et al.
Lung Cancer (Amsterdam, Netherlands)|December 3, 2014
Gene mutations in small-cell lung cancer (SCLC): results of a panel of 6 genes in a cohort of Italian patientsPaola Bordi, Marcello Tiseo, Fausto Barbieri, et al.
Lung Cancer (Amsterdam, Netherlands)|December 4, 2014
Response to dabrafenib after progression on vemurafenib in a patient with advanced BRAF V600E-mutant bronchial adenocarcinomaS Schmid, M Siano, M Joerger, et al.
Lung Cancer (Amsterdam, Netherlands)|October 19, 2015
Reproductive factors and lung cancer risk among women in the Singapore Breast Cancer Screening ProjectHui Shan Tan, Min-Han Tan, Khuan Yew Chow, et al.
Lung Cancer (Amsterdam, Netherlands)|October 20, 2015
Treatment of isolated mediastinal and hilar recurrence of lung cancer with bronchoscopic endobronchial ultrasound guided intratumoral injection of chemotherapy with cisplatinHiren J Mehta, Abbie Begnaud, Andrea M Penley, et al.
Lung Cancer (Amsterdam, Netherlands)|October 24, 2015
EGFR mutation detection in ctDNA from NSCLC patient plasma: A cross-platform comparison of leading technologies to support the clinical development of AZD9291Kenneth S Thress, Roz Brant, T Hedley Carr, et al.
Lung Cancer (Amsterdam, Netherlands)|October 18, 2015
Phase 1 study of romidepsin plus erlotinib in advanced non-small cell lung cancerDavid E Gerber, David A Boothman, Farjana J Fattah, et al.
Lung Cancer (Amsterdam, Netherlands)|November 1, 2015
First line crizotinib in anaplastic lymphoma kinase (ALK) rearranged squamous cell lung cancerRomana E Mikes, Franziska Jordan, Georg Hutarew, et al.
Lung Cancer (Amsterdam, Netherlands)|October 11, 2015
Successful treatment with alectinib after crizotinib-induced interstitial lung diseaseHaruka Chino, Akimasa Sekine, Hideya Kitamura, et al.
Lung Cancer (Amsterdam, Netherlands)|November 9, 2015
MET gene exon 14 deletion created using the CRISPR/Cas9 system enhances cellular growth and sensitivity to a MET inhibitorYosuke Togashi, Hiroshi Mizuuchi, Shuta Tomida, et al.
Pageof 700